当前位置: X-MOL 学术Ageing Res. Rev. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Mitophagy Receptors and Mediators: Therapeutic Targets in the Management of Cardiovascular Ageing.
Ageing Research Reviews ( IF 12.5 ) Pub Date : 2020-07-22 , DOI: 10.1016/j.arr.2020.101129
Amir Ajoolabady 1 , Hamid Aslkhodapasandhokmabad 2 , Ayuob Aghanejad 3 , Yingmei Zhang 4 , Jun Ren 5
Affiliation  

Mitophagy serves as a cardinal regulator in the maintenance of mitochondrial integrity, function, and cardiovascular homeostasis, through the fine control and governance of cellular metabolism, ATP production, redox balance, and mitochondrial quality and quantity control. As a unique form of selective autophagy, mitophagy specifically recognizes and engulfs long-lived or damaged (depolarized) mitochondria through formation of the double-membraned intracellular organelles - mitophagosomes, ultimately resulting in lysosomal degradation. Levels of mitophagy are reported to be altered in pathological settings including cardiovascular diseases and biological ageing although the precise nature of mitophagy change in ageing and ageing-associated cardiovascular deterioration remains poorly defined. Ample clinical and experimental evidence has depicted a convincing tie between cardiovascular ageing and altered mitophagy. In particular, ageing perturbs multiple enigmatic various signal machineries governing mitophagy, mitochondrial quality, and mitochondrial function, contributing to ageing-elicited anomalies in the cardiovascular system. This review will update novel regulatory mechanisms of mitophagy especially in the perspective of advanced ageing, and discuss how mitophagy dysregulation may be linked to cardiovascular abnormalities in ageing. We hope to pave the way for development of new therapeutic strategies against the growing health and socieconomical issue of cardiovascular ageing through targeting mitophagy.



中文翻译:

线粒体受体和介体:心血管衰老管理中的治疗目标。

线粒体通过细胞代谢,ATP产生,氧化还原平衡以及线粒体质和量控制的精细控制和控制,在维持线粒体完整性,功能和心血管稳态方面起着主要的调节作用。作为选择性自噬的一种独特形式,线粒体通过形成双膜细胞内细胞器(线粒体)来特异性识别并吞噬长寿或受损(去极化)的线粒体,最终导致溶酶体降解。据报道,在包括心血管疾病和生物衰老在内的病理环境中,线粒体的水平发生了变化,尽管衰老和与衰老相关的心血管恶化的线粒体变化的确切性质仍然不清楚。大量的临床和实验证据表明,心血管衰老与线粒体改变之间存在令人信服的联系。特别是,衰老扰乱了控制线粒体,线粒体质量和线粒体功能的多种神秘的各种信号机制,从而导致了心血管系统中衰老引起的异常。这篇综述将更新线粒体的新型调控机制,尤其是在晚期衰老的角度,并讨论线粒体失调可能与衰老中的心血管异常有关。我们希望通过针对靶点吞噬技术,为应对日益严重的心血管衰老的健康和社会经济问题铺平道路。衰老扰乱了控制线粒体,线粒体质量和线粒体功能的多种神秘的各种信号机制,导致了心血管系统中衰老引起的异常。这篇综述将更新线粒体的新型调控机制,尤其是在晚期衰老的角度,并讨论线粒体失调可能与衰老中的心血管异常有关。我们希望通过靶向线粒体细胞学为发展新的治疗策略铺平道路,以应对日益严重的心血管衰老的健康和社会经济问题。衰老扰乱了控制线粒体,线粒体质量和线粒体功能的多种神秘的各种信号机制,导致了心血管系统中衰老引起的异常。这篇综述将更新线粒体的新型调控机制,尤其是在晚期衰老的角度,并讨论线粒体失调可能与衰老中的心血管异常有关。我们希望通过针对靶点吞噬技术,为应对日益严重的心血管衰老的健康和社会经济问题铺平道路。这篇综述将更新线粒体的新型调控机制,尤其是在晚期衰老的角度,并讨论线粒体失调可能与衰老中的心血管异常有关。我们希望通过靶向线粒体细胞学为发展新的治疗策略铺平道路,以应对日益严重的心血管衰老的健康和社会经济问题。这篇综述将更新线粒体的新型调控机制,尤其是在晚期衰老的角度,并讨论线粒体失调可能与衰老中的心血管异常有关。我们希望通过靶向线粒体细胞学为发展新的治疗策略铺平道路,以应对日益严重的心血管衰老的健康和社会经济问题。

更新日期:2020-07-22
down
wechat
bug